VITEK MS
Regulatory Status Disclosed
Overview
VITEK MS by bioMérieux is an automated mass spectrometry system utilizing Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) technology for the rapid identification of microorganisms from clinical cultures.
- What it does: VITEK MS identifies bacteria and fungi, including mycobacteria, Nocardia, and molds, by analyzing their protein makeup to create a unique spectral fingerprint. This spectrum is then compared to a comprehensive database for identification.
- Who it is for: This tool is primarily for microbiology laboratories in healthcare settings to aid in the diagnosis of bacterial and fungal infections. It supports infectious disease specialists by providing timely microbial identification.
- How it fits a clinical or practice workflow: VITEK MS is designed for an optimized workflow in the microbiology laboratory. It can process up to 192 isolates per run across four target slides, allowing for parallel sample preparation. The system integrates with bioMérieux’s MYLA middleware, which provides real-time reporting and seamless integration of identification (ID) and antimicrobial susceptibility testing (AST) results when used with VITEK 2 systems.
- Notable capabilities: VITEK MS offers rapid identification, often in minutes. Its database is built to account for diversity within species, aiming for robust and accurate performance. The system has an FDA 510(k) cleared database for bacteria and fungi, including difficult-to-identify organisms such as *Brucella*, *Candida auris*, and *Elizabethkingia anophelis*. It also features a user-friendly interface and continuous load-and-go capabilities for enhanced traceability and productivity.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
What Physicians Need to Know
LIS/LIMS Integration
Seamless integration with Laboratory Information Systems (LIS) and Laboratory Information Management Systems (LIMS) is achieved through bioMu00e9rieux's MYLAu00ae middleware. MYLAu00ae consolidates identification (ID) and antimicrobial susceptibility testing (AST) results from VITEK MS and VITEK 2, providing real-time reporting and allowing all laboratory data to be grouped and viewed in one place. VITEK MS PRIME is also LIMS-compatible for data tracking and compliance.
Supported Assay Types
VITEK MS utilizes MALDI-TOF (Matrix Assisted Laser Desorption Ionization Time-of-Flight) technology for rapid microbial identification. It supports the identification of a broad spectrum of microorganisms, including bacteria, yeasts, molds, mycobacteria, and Nocardia. The comprehensive and continuously expanding FDA 510(k) cleared database includes clinically relevant species such as Brucella, Candida auris, and Elizabethkingia anophelis.
QC/QA Features
The system incorporates multiple quality control checks during analysis to ensure reliable results. It features barcoded reagents and disposable target slides for complete traceability, linking ID with AST results for each isolate. Automatic verification of operation, tuning, and alignment is transparent to the user, and the VITEK MS PRIME offers automated fine-tuning to maximize system uptime and reliability.
Result Interpretation AI
VITEK MS employs a proprietary Advanced Spectra Classifier algorithm and a population-built database for robust and accurate identification. Instead of simple spectral comparisons, the system reads each spectrum as a series of peaks, considering every peak in the calculation using a weighted bin matrix and binning algorithm. This approach enables unambiguous identification with a high confidence level, often greater than 99%.
Critical Value Alerts
While not explicitly termed 'critical value alerts' in the traditional sense for quantitative results, the VITEK MS system, through its rapid identification capabilities and integration with MYLAu00ae middleware, facilitates the delivery of fast and actionable results to clinicians. This enables quicker recognition and response to critical pathogens, supporting informed treatment decisions and antimicrobial stewardship.
Instrument Interfaces
VITEK MS is designed for seamless integration within the microbiology laboratory. It connects directly with the VITEK 2 system for antimicrobial susceptibility testing (AST), often facilitated by MYLAu00ae middleware, to provide a comprehensive ID/AST solution. The VITEK MS Prep Station can also set up AST cards for VITEK 2, and VITEK FLEXPREPu2122 software further enhances integration with VITEK 2 and VITEK DENSICHEKu00ae.
Reference Range Intelligence
The system's robust database is built to account for extensive intra-species diversity, incorporating spectra from numerous strains (an average of 12-17 strains per species) with varied geographical origins, sample types, culture media, and incubation conditions. This comprehensive data collection enhances the accuracy and reliability of microbial identification, providing high confidence in species-level results.
Turnaround Time Impact
VITEK MS significantly reduces the turnaround time for microbial identification, providing results in minutes compared to traditional phenotypic methods that can take 24-48 hours. This rapid identification enables clinicians to initiate appropriate, targeted antimicrobial therapy much earlier, leading to improved patient outcomes and supporting antimicrobial stewardship programs.
Microbiology ID Support
As its primary function, VITEK MS provides rapid, accurate, and confident species-level identification of a wide array of microorganisms using MALDI-TOF mass spectrometry. Its comprehensive and evolving database, coupled with the Advanced Spectra Classifier, ensures high diagnostic accuracy for bacteria, yeasts, molds, mycobacteria, and Nocardia, including emerging and difficult-to-identify pathogens.
Physician Tip
VITEK MS provides rapid and accurate microbial identification, often within minutes, which is crucial for timely clinical decision-making. This speed allows for earlier initiation of targeted antimicrobial therapy, potentially improving patient outcomes and supporting effective antimicrobial stewardship. The comprehensive database, including difficult-to-identify and emerging pathogens, enhances diagnostic confidence. Physicians should leverage these rapid results to tailor treatment plans promptly and collaborate with microbiology for optimal patient management.
The VITEK MS system offers robust integration capabilities, primarily through bioMu00e9rieux's MYLAu00ae middleware. This middleware acts as a central hub, seamlessly connecting VITEK MS for identification with VITEK 2 for antimicrobial susceptibility testing, and subsequently with the laboratory's LIS/LIMS. This integrated workflow ensures end-to-end traceability, consolidated reporting, and efficient data management across the microbiology laboratory, streamlining operations and facilitating comprehensive data analysis.
Details
| Category | Lab & Diagnostics |
| Pricing | Unknown |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Infectious Disease, Laboratory Medicine |
What the Web Says
The VITEK MS system is a MALDI-TOF mass spectrometry system used for rapid and accurate identification of microorganisms in clinical microbiology laboratories. It is generally well-regarded by users for its speed and ease of use, significantly improving turnaround times for pathogen identification compared to traditional methods. The system aids in antimicrobial stewardship by providing faster results, leading to more informed treatment decisions and potentially reducing unnecessary antibiotic use.
Overall: PositiveStrengths
- Rapid and accurate identification of bacteria and fungi, including mycobacteria, Nocardia, and molds.
- Significantly faster turnaround times for pathogen identification compared to traditional methods, improving patient outcomes.
- Easy to learn and use, even for students, with straightforward procedures.
- Robust and accurate results due to its Advanced Spectra Classifier and population-built database.
- Seamless integration of identification and antimicrobial susceptibility testing (AST) results with MYLAu00ae middleware.
- Reduced hands-on time and optimized workflow, especially with the VITEK MS PRIME's continuous load-and-go system and urgent sample prioritization.
Limitations
- May not identify common gram-positive bacilli and some other organisms as well as other instruments.
- Older instruments can have frequent mechanical problems.
- Requires frequent calibration.
- Limited identification for certain bugs compared to MALDI-TOF systems from other manufacturers, and prone to giving false 'good' IDs for some organisms.
- The cost may not be justifiable for labs that do not have a high throughput of samples.
- Database needs continuous updates to include rare and unusual gram-positive organisms.
Based on reviews from: bioMu00e9rieux, Reddit, RedEMC, ASM Journals, PLOS One
Last updated: 2026-07-21
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate VITEK MS
Press & Coverage
bioMu00e9rieux
bioMu00e9rieux receives FDA 510(k) clearance for its VITEKu00ae MS PRIME new MALDI-TOF mass spectrometry identification system
bioMu00e9rieux announced that its new VITEKu00ae MS PRIME MALDI-TOF mass spectrometry identification system received 510(k) clearance from the U.S. FDA, making it commercially available in the US and CE-marked countries. This compact benchtop system is designed to provide rapid microbial identification and enhance laboratory workflow efficiency, particularly relevant during the COVID-19 pandemic.
2022-03
CAP TODAY
BioMu00e9rieux gets FDA 510(k) clearance for Vitek MS Prime - CAP TODAY
BioMu00e9rieux's Vitek MS Prime, a new MALDI-TOF mass spectrometry identification system, received FDA 510(k) clearance. The system offers rapid microorganism identification from microbial cultures and integrates with Vitek 2 for antimicrobial susceptibility testing.
2022-03
LabMedica
BioMu00e9rieux's New CE-Marked Mass Spectrometry System Makes Lab Life Easier During COVID-19 Pandemic - LabMedica
BioMu00e9rieux announced the CE-marking of VITEK MS PRIME, its next-generation MALDI-TOF mass spectrometry system, which aims to simplify lab operations during the COVID-19 pandemic. The system provides rapid and accurate microbial identification, supporting antimicrobial stewardship programs.
2021-05
ASM Journals
Performance and workflow comparison of the VITEK MS PRIME and Bruker Biotyper MALDI-TOF MS systems - ASM Journals
This study evaluates the VITEK MS PRIME MALDI-TOF MS system, comparing its performance and workflow efficiency against the Bruker MALDI Biotyper for isolate identification from positive blood cultures. The research highlights potential time savings in high-throughput settings.
2025-06
ASM Journals
Multi-year comparison of VITEK MS performance for identification of rarely encountered pathogenic gram-positive organisms (GPOs) in a large integrated Canadian healthcare region | Microbiology Spectrum - ASM Journals
This study assessed the VITEK MS system's performance in identifying rare and unusual gram-positive organisms over several years in a Canadian healthcare region. It found that while most GPOs were accurately identified, continuous database updates are crucial for comprehensive identification.
2025-04
ASM Journals
Multi-year comparison of VITEK MS performance for identification of rarely encountered pathogenic Gram-negative organisms (GNOs) in a large integrated Canadian healthcare region | Microbiology Spectrum - ASM Journals
This multi-year study compared VITEK MS to 16S rRNA gene sequencing for identifying rare Gram-negative organisms, noting stable performance for some groups but highlighting the need for database updates for others. The study emphasizes the challenges rare organisms pose to current MALDI-TOF technology.
2024-10
PLOS One
Performance of the VITEKu00ae MS system for the identification of filamentous fungi in a microbiological laboratory in Chile | PLOS One - Research journals
This study evaluated the VITEK MS system's ability to identify filamentous fungi in a clinical laboratory in Chile, demonstrating a high capability for accurate identification. The system showed a significant reduction in identification time compared to traditional methods.
2024-12
FDA
MAUDE Adverse Event Report: BIOMERIEUX, SA VITEK MS
An FDA adverse event report details a misidentification of Staphylococcus epidermidis as Paracoccus yeei by a VITEK MS instrument in a pharmaceutical customer's lab. An internal investigation by bioMu00e9rieux attributed the issue to a mixed culture rather than a product malfunction.
2026-05
Videos
Product demos, reviews, and walkthroughs for VITEK MS.
VITEK MS: Sample Prep - Bacteria and Yeast the VITEK PICKME Pen
bioMu00e9rieux University
VITEKu00ae MS - System principle
bioMu00e9rieux
VITEKu00ae MS PRIME
bioMu00e9rieux
Microbial Identification | Vitek 2 Compact | Vitek MS u200bu200bu2060
Microbiology Mantra
ACM Pharma trusts VITEKu00ae MS PRIME to ensure their microbial identification activities
bioMu00e9rieux
US | VITEKu00ae MS Spot Preparation Using VITEK PICKMEu2122
bioMu00e9rieux
Frequently Asked Questions
VITEK MS employs a proprietary Advanced Spectra Classifier algorithm that analyzes each spectrum as a series of peaks, considering every peak in the calculation for identification results. This method, combined with a comprehensive, population-built database accounting for intra-species diversity, contributes to robust and accurate microbial identification. The system has demonstrated high accuracy, with an overall accuracy of 93.6% compared to 16S ribosomal RNA gene sequencing for various microbial pathogens.
VITEK MS is FDA 510(k) cleared for clinical use and is 21 CFR Part 11 Compliant, which addresses electronic records and electronic signatures, ensuring data integrity and traceability. BioMu00e9rieux also outlines its principles for processing personal data in its privacy notice, covering aspects like data minimization and individual rights, relevant for clinical customer support.
A primary alternative to VITEK MS is the Bruker Microflex MS (Biotyper) system, both utilizing MALDI-TOF technology for rapid microbial identification. While both systems offer high accuracy, VITEK MS PRIME has shown higher identification rates and shorter turnaround times in some comparative studies, particularly for certain organisms and after short-incubation blood cultures. The choice often depends on specific laboratory workflow needs and preferences, as VITEK MS offers a more streamlined user experience with ready-to-use supplies and easier connectivity.
The cost of a VITEK MS system can vary, with some used systems listed around $3,150 to $50,000, though new system pricing would be higher and typically involves a broader contract. While specific cost-effectiveness data for its AI features are not explicitly detailed, MALDI-TOF systems like VITEK MS are generally considered cost-effective compared to conventional or molecular methods due to rapid identification, which can lead to savings in time and other diagnostic resources.
Despite its advanced algorithms and comprehensive database, VITEK MS may have limitations such as occasional misidentification or inability to identify certain species, particularly if they are not adequately represented in its database. While it provides rapid identification, it does not perform antimicrobial susceptibility testing (AST) for all antibiotics, meaning physicians may still need to await further testing for definitive treatment decisions. Experienced laboratory personnel are crucial for managing results and considering other clinical and laboratory findings.
VITEK MS is designed for optimized workflow and seamless integration of identification (ID) and antimicrobial susceptibility testing (AST) results, often through middleware solutions like MYLA. By providing rapid and highly accurate pathogen identification, it positively impacts antimicrobial stewardship programs, enabling earlier, targeted therapy and contributing to more efficient patient care.
BioMu00e9rieux continuously expands the VITEK MS database to include new emerging pathogens and clinically relevant species, such as Brucella, Candida auris, and Elizabethkingia anophelis. The database is built with extensive strain diversity, including geographical and sample origin variations, to ensure robust and accurate performance. Users can expect ongoing support and updates to maintain and enhance the system's diagnostic accuracy.
Suggest an Edit →
| Last Verified: 2026-04-20 | First Added: 2026-04-20